OKYO Pharma CEO Announces First Dosing in Phase 2 Trial for OK-101 to Treat Neuropathic Corneal Pain

By Proactive Investors / October 24, 2024 / www.youtube.com / Article Link


OKYO Pharma CEO Gary Jacob joined Steve Darling from Proactive to share news the company is reporting the first patient has ...

Recent News

Big Gold has another strong quarter, but some signs growth cooling

May 12, 2025 / www.canadianminingreport.com

Gold stocks nearly regain highs on rising metal price

May 12, 2025 / www.canadianminingreport.com

Gold stocks down as risk on move continues

May 05, 2025 / www.canadianminingreport.com

Mixed outlook for resources on new Canadian government

May 05, 2025 / www.canadianminingreport.com

Gold's Bull Market Pullbacks

April 28, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok